Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach.
about
Retooling Laser Speckle Contrast Analysis Algorithm to Enhance Non-Invasive High Resolution Laser Speckle Functional Imaging of Cutaneous Microcirculation.Endothelial dysfunction and oxidative stress in polycystic kidney disease.Evaluation of microvascular reactivity with laser Doppler flowmetry in chronic kidney diseasePeripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney diseaseInterrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving HemodialysisAlbuminuria and Endothelial Dysfunction in Patients with Non-Diabetic Chronic Kidney Disease.The urea decomposition product cyanate promotes endothelial dysfunction.Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease.The uremic toxin hippurate promotes endothelial dysfunction via the activation of Drp1-mediated mitochondrial fission.Arterial stiffness but not endothelial dysfunction is associated with multidrug antihypertensive therapy and nondipper blood pressure pattern in kidney transplant recipients
P2860
Q30835615-99DF3CA1-9B43-443A-B1F9-9C31D2B6306DQ34627589-8987F094-030E-4C20-9A36-93418AAE20E9Q35047495-FB91CF78-AAAA-4897-96DB-5F6FE15643C9Q35466141-D3901AC1-8AD8-49F8-B245-AD6D31B8E596Q35679843-343D8A33-71F5-495F-A222-15DCCDAF31C8Q36020478-437561D2-BAE7-473B-9375-F0D41B949652Q41814933-A00619B9-013A-42BD-93CD-97CBCD4A2CD1Q42025075-1A221BED-8B6B-4E81-8C9E-E81BDB9FA0F6Q47995071-4D0C6148-EF8F-4CCC-9D23-147DC7669FF5Q48939498-84F32160-EAAB-41B8-9DEA-164633BC3688Q55414253-34257E4E-EAB0-48D9-B272-866BBA387FDDQ58759245-43F480E9-B120-44A2-885B-6F72FAD002E8
P2860
Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Methods and potential biomarke ...... disease: a critical approach.
@ast
Methods and potential biomarke ...... disease: a critical approach.
@en
type
label
Methods and potential biomarke ...... disease: a critical approach.
@ast
Methods and potential biomarke ...... disease: a critical approach.
@en
prefLabel
Methods and potential biomarke ...... disease: a critical approach.
@ast
Methods and potential biomarke ...... disease: a critical approach.
@en
P2093
P1476
Methods and potential biomarke ...... disease: a critical approach.
@en
P2093
Dragomir N Serban
Ionela Lacramioara Serban
Liviu Segall
Luminita Voroneanu
Mihai M Hogas
Simona M Hogas
P304
P356
10.1016/J.JASH.2010.03.008
P50
P577
2010-05-01T00:00:00Z